Plasmodium falciparum Malaria Protein 010 (FMP010)

BIOLOGICAL2 trials

Sponsors

U.S. Army Medical Research and Development Command

Conditions

Malaria

Phase 1

A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya

CompletedNCT00666380

U.S. Army Medical Research and Development CommandMalaria

Start: 2008-04-30End: 2009-06-30Updated: 2015-05-29

Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B

CompletedNCT02458092

U.S. Army Medical Research and Development CommandMalaria

Start: 2008-04-30End: 2009-06-30Updated: 2023-06-28

Related Papers

Comparison of PfHRP-2/pLDH ELISA, qPCR and microscopy for the detection of plasmodium events and prediction of sick visits during a malaria vaccine study.

2013-03-1518 citations

Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.

2013-01-2330 citations